نتائج البحث - "Sunita Badola"

المساهمون: Di Bacco A., Bahlis N.J., Munshi N.C., Avet-Loiseau H., Masszi T., Viterbo L., Pour L., Ganly P., Cavo M., Langer C., Kumar S.K., Rajkumar S.V., Keats J.J., Berg D., Lin J., Li B., Badola S., Shen L., Zhang J., Esseltine D.-L., Luptakova K., van de Velde H., Richardson P.G., Moreau P.

المصدر: European Journal of Haematology

مصطلحات موضوعية: Oncology, Male, Gene Expression, Dexamethasone, Ixazomib, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Lenalidomide, Multiple myeloma, Aged, 80 and over, Hazard ratio, RNA sequencing, Hematology, General Medicine, Middle Aged, Prognosis, multiple myeloma, Prior Therapy, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Original Article, c‐myc Proto‐Oncogenes, medicine.drug, Boron Compounds, medicine.medical_specialty, Glycine, Proto-Oncogene Proteins c-myc, 03 medical and health sciences, Internal medicine, medicine, Biomarkers, Tumor, Humans, c-myc Proto-Oncogene, Progression-free survival, Aged, Neoplasm Staging, business.industry, Gene Expression Profiling, progression‐free survival, Original Articles, medicine.disease, Transplantation, chemistry, Neoplasm Grading, mutation, business, progression-free survival, 030215 immunology

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26945d840f6982261316ede63224f299Test
http://hdl.handle.net/11585/804167Test

8

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

المصدر: Journal of Thoracic Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Alisertib, Lung Neoplasms, Paclitaxel, Population, Phases of clinical research, Placebo, Disease-Free Survival, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Refractory, Double-Blind Method, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, medicine, small-cell lung cancer, Humans, education, Retrospective Studies, education.field_of_study, business.industry, Hazard ratio, SCLC, Azepines, Phase II, 030104 developmental biology, Pyrimidines, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Aurora A kinase, Neoplasm Recurrence, Local, business, Biomarkers

وصف الملف: Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a96c0e2d242d5e686470324fde43d32bTest
https://pubmed.ncbi.nlm.nih.gov/31655296Test

9

Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors

المؤلفون: Anthony W. Tolcher, William D. Tap, Ian M. Leitch, Richard Tozer, Petr Kavan, Jayesh Desai, Phillip Barnette, Min Zhu, Sunita Badola, Ian McCaffery, George D. Demetri, Sung Chang, Gregory Friberg, Pasquale Benedetto, Hongjie Deng

المصدر: Journal of Clinical Oncology. 30:1849-1856

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Pathology, Time Factors, Oncogene Proteins, Fusion, Desmoplastic small-round-cell tumor, Phases of clinical research, Bone Neoplasms, Kaplan-Meier Estimate, Sarcoma, Ewing, Desmoplastic Small Round Cell Tumor, Antibodies, Monoclonal, Humanized, Translocation, Genetic, Receptor, IGF Type 1, Young Adult, Growth factor receptor, Internal medicine, medicine, Humans, Insulin-Like Growth Factor I, Adverse effect, In Situ Hybridization, Fluorescence, Aged, Insulin-like growth factor 1 receptor, Proto-Oncogene Protein c-fli-1, Sequence Analysis, RNA, business.industry, Antibodies, Monoclonal, Cancer, Middle Aged, medicine.disease, Treatment Outcome, Monoclonal, Female, Sarcoma, RNA-Binding Protein EWS, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd5a60704be55d1d3b366632c19193fTest
https://doi.org/10.1200/jco.2011.37.2359Test

10

Abstract CT164: Circulating tumor DNA analysis for predictive and prognostic factors in patients with metastatic colorectal cancer: An exploratory analysis from the phase III PARADIGM study

المصدر: Cancer Research. 78:CT164-CT164

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, business.industry, Colorectal cancer, Cancer, Microsatellite instability, medicine.disease, Somatic evolution in cancer, DNA sequencing, Internal medicine, Medicine, Panitumumab, Biomarker (medicine), business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bc8f3a184f73da2a3b3b3c3df1fc6b13Test
https://doi.org/10.1158/1538-7445.am2018-ct164Test

تنقيح النتائج